Pfizer more than doubled the price of COVID-19 treatment drug Paxlovid

Pfizer more than doubled the price of COVID-19 treatment drug Paxlovid

Drugmaker Pfizer said Wednesday that the price of its life-saving COVID-19 antiviral drug Paxlovid will more than double as the United States emerges from the emergency phase of the pandemic. The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. This is 2.6 times higher than the $530/course … Read more

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access | CNN

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access |  CNN

CNN — Prices for the Covid-19 drug Paxlovid will likely rise next year for most patients as the United States continues to move out of the emergency phase of the pandemic, raising concerns among doctors that the drug will become more difficult to reach. Just like this season’s Covid-19 vaccine, the combination antiviral drug nirmatrelvir … Read more

Court order requiring pharmacies to fill prescription drugs sparks COVID-19 controversy – Iowa Capital Dispatch

Court order requiring pharmacies to fill prescription drugs sparks COVID-19 controversy - Iowa Capital Dispatch

An Iowa doctor is seeking a court order requiring pharmacies to fill the prescription drugs hydroxychloroquine and ivermectin to treat COVID-19. The order is being sought as part of a civil lawsuit brought by Dr. David Hartsuch, an emergency physician from Bettendorf, against the Iowa Board of Medicine and the Iowa Board of Pharmacy in … Read more

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access | CNN

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access |  CNN

Stephanie Nano/AP/File Paxlovid will move from making it free to everyone through government purchases to the more traditional commercial market later this year. CNN Prices for the Covid-19 drug Paxlovid will likely rise next year for most patients as the United States continues to move out of the emergency phase of the pandemic, raising concerns … Read more